Local infusion of FGF-saporin reduces intimai hyperplasia

Samer Mattar, Stephen R. Hanson, Glenn F. Pierce, Changyi Chen, John D. Hughes, Jennifer E. Cook, Chun Shen, Beverly A. Noe, Carolyn R. Suwyn, J. Ryland Scott, Alan B. Lumsden

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The recent conjugation of the potent ribosome-inactivating protein saporin (SAP) with basic fibroblast growth factor (FGF2) to form recombinant (r)FGF2-SAP permits increased, selectivity of this mitoxin for cells exhibiting upregulated FGF receptors. Systemic administration of rFGF-SAP in therapeutic doses, however, may be associated with significant liver toxicity. In this blinded study, we used a local boundary layer infusion approach to increase local drug concentration while minimizing the risk of side effects. Six dogs underwent bilateral carotid endarterectomies. Expanded polytetrafluoroethylene infusion devices, blindly primed with rFGF2-SAP to one artery or vehicle to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. rFGF2-SAP (2 μg/kg/day) or vehicle (5 μ1/hr) was continuously delivered for 14 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 14 days and the processed arteries were blindly analyzed for intimal thickening and cellular proliferation. All dogs survived until sacrifice with no clinical side effects. Liver function tests at euthanasia were not significantly altered when compared to baseline values. Intimal area in rFGF2-SAP-treated vessels averaged 0.31 ± 0.10 mm2 versus 0.57 ± 0.24 mm2 in the control segments (P = 0.02), a relative reduction of 46%. Cell proliferation, however, was not significantly different at 14 days postendarterectomy (2.40 ± 1.31% vs 2.39 ± 0.45%). From this study it can be concluded that locally delivered rFGF2-SAP reduces intimal hyperplasia and that the boundary layer infusion strategy is an effective means for delivering high local drug concentration while minimizing systemic drug effects.

Original languageEnglish (US)
Pages (from-to)339-344
Number of pages6
JournalJournal of Surgical Research
Volume60
Issue number2
DOIs
StatePublished - Feb 1 1996
Externally publishedYes

Fingerprint

Hyperplasia
Tunica Intima
Fibroblast Growth Factor 2
Euthanasia
Arteries
Cell Proliferation
Ribosome Inactivating Proteins
Pharmaceutical Preparations
Dogs
Fibroblast Growth Factor Receptors
Equipment and Supplies
Carotid Endarterectomy
Liver Function Tests
Polytetrafluoroethylene
saporin
Transplants
Liver

ASJC Scopus subject areas

  • Surgery

Cite this

Mattar, S., Hanson, S. R., Pierce, G. F., Chen, C., Hughes, J. D., Cook, J. E., ... Lumsden, A. B. (1996). Local infusion of FGF-saporin reduces intimai hyperplasia. Journal of Surgical Research, 60(2), 339-344. https://doi.org/10.1006/jsre.1996.0054

Local infusion of FGF-saporin reduces intimai hyperplasia. / Mattar, Samer; Hanson, Stephen R.; Pierce, Glenn F.; Chen, Changyi; Hughes, John D.; Cook, Jennifer E.; Shen, Chun; Noe, Beverly A.; Suwyn, Carolyn R.; Scott, J. Ryland; Lumsden, Alan B.

In: Journal of Surgical Research, Vol. 60, No. 2, 01.02.1996, p. 339-344.

Research output: Contribution to journalArticle

Mattar, S, Hanson, SR, Pierce, GF, Chen, C, Hughes, JD, Cook, JE, Shen, C, Noe, BA, Suwyn, CR, Scott, JR & Lumsden, AB 1996, 'Local infusion of FGF-saporin reduces intimai hyperplasia', Journal of Surgical Research, vol. 60, no. 2, pp. 339-344. https://doi.org/10.1006/jsre.1996.0054
Mattar S, Hanson SR, Pierce GF, Chen C, Hughes JD, Cook JE et al. Local infusion of FGF-saporin reduces intimai hyperplasia. Journal of Surgical Research. 1996 Feb 1;60(2):339-344. https://doi.org/10.1006/jsre.1996.0054
Mattar, Samer ; Hanson, Stephen R. ; Pierce, Glenn F. ; Chen, Changyi ; Hughes, John D. ; Cook, Jennifer E. ; Shen, Chun ; Noe, Beverly A. ; Suwyn, Carolyn R. ; Scott, J. Ryland ; Lumsden, Alan B. / Local infusion of FGF-saporin reduces intimai hyperplasia. In: Journal of Surgical Research. 1996 ; Vol. 60, No. 2. pp. 339-344.
@article{da5d79d28d5c4bf4ac333cd21c06fcdf,
title = "Local infusion of FGF-saporin reduces intimai hyperplasia",
abstract = "The recent conjugation of the potent ribosome-inactivating protein saporin (SAP) with basic fibroblast growth factor (FGF2) to form recombinant (r)FGF2-SAP permits increased, selectivity of this mitoxin for cells exhibiting upregulated FGF receptors. Systemic administration of rFGF-SAP in therapeutic doses, however, may be associated with significant liver toxicity. In this blinded study, we used a local boundary layer infusion approach to increase local drug concentration while minimizing the risk of side effects. Six dogs underwent bilateral carotid endarterectomies. Expanded polytetrafluoroethylene infusion devices, blindly primed with rFGF2-SAP to one artery or vehicle to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. rFGF2-SAP (2 μg/kg/day) or vehicle (5 μ1/hr) was continuously delivered for 14 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 14 days and the processed arteries were blindly analyzed for intimal thickening and cellular proliferation. All dogs survived until sacrifice with no clinical side effects. Liver function tests at euthanasia were not significantly altered when compared to baseline values. Intimal area in rFGF2-SAP-treated vessels averaged 0.31 ± 0.10 mm2 versus 0.57 ± 0.24 mm2 in the control segments (P = 0.02), a relative reduction of 46{\%}. Cell proliferation, however, was not significantly different at 14 days postendarterectomy (2.40 ± 1.31{\%} vs 2.39 ± 0.45{\%}). From this study it can be concluded that locally delivered rFGF2-SAP reduces intimal hyperplasia and that the boundary layer infusion strategy is an effective means for delivering high local drug concentration while minimizing systemic drug effects.",
author = "Samer Mattar and Hanson, {Stephen R.} and Pierce, {Glenn F.} and Changyi Chen and Hughes, {John D.} and Cook, {Jennifer E.} and Chun Shen and Noe, {Beverly A.} and Suwyn, {Carolyn R.} and Scott, {J. Ryland} and Lumsden, {Alan B.}",
year = "1996",
month = "2",
day = "1",
doi = "10.1006/jsre.1996.0054",
language = "English (US)",
volume = "60",
pages = "339--344",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Local infusion of FGF-saporin reduces intimai hyperplasia

AU - Mattar, Samer

AU - Hanson, Stephen R.

AU - Pierce, Glenn F.

AU - Chen, Changyi

AU - Hughes, John D.

AU - Cook, Jennifer E.

AU - Shen, Chun

AU - Noe, Beverly A.

AU - Suwyn, Carolyn R.

AU - Scott, J. Ryland

AU - Lumsden, Alan B.

PY - 1996/2/1

Y1 - 1996/2/1

N2 - The recent conjugation of the potent ribosome-inactivating protein saporin (SAP) with basic fibroblast growth factor (FGF2) to form recombinant (r)FGF2-SAP permits increased, selectivity of this mitoxin for cells exhibiting upregulated FGF receptors. Systemic administration of rFGF-SAP in therapeutic doses, however, may be associated with significant liver toxicity. In this blinded study, we used a local boundary layer infusion approach to increase local drug concentration while minimizing the risk of side effects. Six dogs underwent bilateral carotid endarterectomies. Expanded polytetrafluoroethylene infusion devices, blindly primed with rFGF2-SAP to one artery or vehicle to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. rFGF2-SAP (2 μg/kg/day) or vehicle (5 μ1/hr) was continuously delivered for 14 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 14 days and the processed arteries were blindly analyzed for intimal thickening and cellular proliferation. All dogs survived until sacrifice with no clinical side effects. Liver function tests at euthanasia were not significantly altered when compared to baseline values. Intimal area in rFGF2-SAP-treated vessels averaged 0.31 ± 0.10 mm2 versus 0.57 ± 0.24 mm2 in the control segments (P = 0.02), a relative reduction of 46%. Cell proliferation, however, was not significantly different at 14 days postendarterectomy (2.40 ± 1.31% vs 2.39 ± 0.45%). From this study it can be concluded that locally delivered rFGF2-SAP reduces intimal hyperplasia and that the boundary layer infusion strategy is an effective means for delivering high local drug concentration while minimizing systemic drug effects.

AB - The recent conjugation of the potent ribosome-inactivating protein saporin (SAP) with basic fibroblast growth factor (FGF2) to form recombinant (r)FGF2-SAP permits increased, selectivity of this mitoxin for cells exhibiting upregulated FGF receptors. Systemic administration of rFGF-SAP in therapeutic doses, however, may be associated with significant liver toxicity. In this blinded study, we used a local boundary layer infusion approach to increase local drug concentration while minimizing the risk of side effects. Six dogs underwent bilateral carotid endarterectomies. Expanded polytetrafluoroethylene infusion devices, blindly primed with rFGF2-SAP to one artery or vehicle to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. rFGF2-SAP (2 μg/kg/day) or vehicle (5 μ1/hr) was continuously delivered for 14 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 14 days and the processed arteries were blindly analyzed for intimal thickening and cellular proliferation. All dogs survived until sacrifice with no clinical side effects. Liver function tests at euthanasia were not significantly altered when compared to baseline values. Intimal area in rFGF2-SAP-treated vessels averaged 0.31 ± 0.10 mm2 versus 0.57 ± 0.24 mm2 in the control segments (P = 0.02), a relative reduction of 46%. Cell proliferation, however, was not significantly different at 14 days postendarterectomy (2.40 ± 1.31% vs 2.39 ± 0.45%). From this study it can be concluded that locally delivered rFGF2-SAP reduces intimal hyperplasia and that the boundary layer infusion strategy is an effective means for delivering high local drug concentration while minimizing systemic drug effects.

UR - http://www.scopus.com/inward/record.url?scp=0030024792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030024792&partnerID=8YFLogxK

U2 - 10.1006/jsre.1996.0054

DO - 10.1006/jsre.1996.0054

M3 - Article

VL - 60

SP - 339

EP - 344

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -